These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 15240597)

  • 1. Pharmacokinetic and pharmacodynamic characteristics of a long-acting growth hormone (GH) preparation (nutropin depot) in GH-deficient children.
    Kemp SF; Fielder PJ; Attie KM; Blethen SL; Reiter EO; Ford KM; Marian M; Dao LN; Lee HJ; Saenger P
    J Clin Endocrinol Metab; 2004 Jul; 89(7):3234-40. PubMed ID: 15240597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacokinetic and pharmacodynamic characteristics of a long-acting growth hormone (GH) preparation (nutropin depot) in GH-deficient adults.
    Cook DM; Biller BM; Vance ML; Hoffman AR; Phillips LS; Ford KM; Benziger DP; Illeperuma A; Blethen SL; Attie KM; Dao LN; Reimann JD; Fielder PJ
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4508-14. PubMed ID: 12364427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age.
    Ranke MB; Traunecker R; Martin DD; Schweizer R; Schwarze CP; Wollmann HA; Binder G
    Horm Res; 2005; 64(2):68-76. PubMed ID: 16113581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic and pharmacodynamic profile of a new sustained-release GH formulation, LB03002, in children with GH deficiency.
    Peter F; Savoy C; Ji HJ; Juhasz M; Bidlingmaier M; Saenger P
    Eur J Endocrinol; 2009 Mar; 160(3):349-55. PubMed ID: 19074465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum free insulin-like growth factor I (IGF-I), total IGF-I, and IGF-binding protein-3 concentrations in normal children and children with growth hormone deficiency.
    Kawai N; Kanzaki S; Takano-Watou S; Tada C; Yamanaka Y; Miyata T; Oka M; Seino Y
    J Clin Endocrinol Metab; 1999 Jan; 84(1):82-9. PubMed ID: 9920066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone (GH) provocative retesting of 108 young adults with childhood-onset GH deficiency and the diagnostic value of insulin-like growth factor I (IGF-I) and IGF-binding protein-3.
    Juul A; Kastrup KW; Pedersen SA; Skakkebaek NE
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1195-201. PubMed ID: 9100596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Free insulin-like growth factor I serum levels in 1430 healthy children and adults, and its diagnostic value in patients suspected of growth hormone deficiency.
    Juul A; Holm K; Kastrup KW; Pedersen SA; Michaelsen KF; Scheike T; Rasmussen S; Müller J; Skakkebaek NE
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2497-502. PubMed ID: 9253324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somapacitan, a once-weekly reversible albumin-binding GH derivative, in children with GH deficiency: A randomized dose-escalation trial.
    Battelino T; Rasmussen MH; De Schepper J; Zuckerman-Levin N; Gucev Z; Sävendahl L;
    Clin Endocrinol (Oxf); 2017 Oct; 87(4):350-358. PubMed ID: 28656605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pegylated long-acting human growth hormone is well-tolerated in healthy subjects and possesses a potential once-weekly pharmacokinetic and pharmacodynamic treatment profile.
    Rasmussen MH; Bysted BV; Anderson TW; Klitgaard T; Madsen J
    J Clin Endocrinol Metab; 2010 Jul; 95(7):3411-7. PubMed ID: 20427496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of oral administration of ibutamoren mesylate, a nonpeptide growth hormone secretagogue, on the growth hormone-insulin-like growth factor I axis in growth hormone-deficient children.
    Codner E; Cassorla F; Tiulpakov AN; Mericq MV; Avila A; Pescovitz OH; Svensson J; Cerchio K; Krupa D; Gertz BJ; Murphy G
    Clin Pharmacol Ther; 2001 Jul; 70(1):91-8. PubMed ID: 11452249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A long-acting human growth hormone (Nutropin Depot): efficacy and safety following two years of treatment in children with growth hormone deficiency.
    Silverman BL; Blethen SL; Reiter EO; Attie KM; Neuwirth RB; Ford KM
    J Pediatr Endocrinol Metab; 2002 May; 15 Suppl 2():715-22. PubMed ID: 12092685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated insulin-like growth factor-I values in children with Prader-Willi syndrome compared with growth hormone (GH) deficiency children over two years of GH treatment.
    Feigerlová E; Diene G; Oliver I; Gennero I; Salles JP; Arnaud C; Tauber M
    J Clin Endocrinol Metab; 2010 Oct; 95(10):4600-8. PubMed ID: 20926543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A low starting dose of genotropin in growth hormone-deficient adults.
    Janssen YJ; Frölich M; Roelfsema F
    J Clin Endocrinol Metab; 1997 Jan; 82(1):129-35. PubMed ID: 8989246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic and Pharmacodynamic Modeling of MOD-4023, a Long-Acting Human Growth Hormone, in Growth Hormone Deficiency Children.
    Fisher DM; Rosenfeld RG; Jaron-Mendelson M; Amitzi L; Koren R; Hart G
    Horm Res Paediatr; 2017; 87(5):324-332. PubMed ID: 28399519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of continuation or cessation of growth hormone (GH) therapy on body composition and metabolic status in adolescents with severe GH deficiency at completion of linear growth.
    Carroll PV; Drake WM; Maher KT; Metcalfe K; Shaw NJ; Dunger DB; Cheetham TD; Camacho-Hübner C; Savage MO; Monson JP
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3890-5. PubMed ID: 15292323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High serum levels of growth hormone (GH) and insulin-like growth factor-I (IGF-I) during high-dose GH treatment in short children born small for gestational age.
    van Dijk M; Mulder P; Houdijk M; Mulder J; Noordam K; Odink RJ; Rongen-Westerlaken C; Voorhoeve P; Waelkens J; Stokvis-Brantsma J; Hokken-Koelega A
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1390-6. PubMed ID: 16464954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new sustained-release preparation of human growth hormone and its pharmacokinetic, pharmacodynamic and safety profile.
    Jostel A; Mukherjee A; Alenfall J; Smethurst L; Shalet SM
    Clin Endocrinol (Oxf); 2005 May; 62(5):623-7. PubMed ID: 15853836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum leptin response to the acute and chronic administration of growth hormone (GH) to elderly subjects with GH deficiency.
    Gill MS; Toogood AA; Jones J; Clayton PE; Shalet SM
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1288-95. PubMed ID: 10199769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical tests in the diagnosis of childhood growth hormone deficiency.
    Tillmann V; Buckler JM; Kibirige MS; Price DA; Shalet SM; Wales JK; Addison MG; Gill MS; Whatmore AJ; Clayton PE
    J Clin Endocrinol Metab; 1997 Feb; 82(2):531-5. PubMed ID: 9024249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel long-acting GH preparations.
    Doknic M; Stojanovic M; Popovic V
    Pediatr Endocrinol Rev; 2014 Dec; 12(2):206-12. PubMed ID: 25581986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.